Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus

[1]  T. Freund,et al.  Dynamic changes of CB1‐receptor expression in hippocampi of epileptic mice and humans , 2010, Epilepsia.

[2]  S. Eggan,et al.  Cannabinoid CB1 Receptor Immunoreactivity in the Prefrontal Cortex: Comparison of Schizophrenia and Major Depressive Disorder , 2010, Neuropsychopharmacology.

[3]  Bret N. Smith,et al.  Cannabinoid-Mediated Inhibition of Recurrent Excitatory Circuitry in the Dentate Gyrus in a Mouse Model of Temporal Lobe Epilepsy , 2010, PloS one.

[4]  B. Alger,et al.  Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses , 2010, Nature Neuroscience.

[5]  J. C. Lodder,et al.  Diacylglycerol Lipase Is Not Involved in Depolarization-Induced Suppression of Inhibition at Unitary Inhibitory Connections in Mouse Hippocampus , 2010, The Journal of Neuroscience.

[6]  Masahiko Watanabe,et al.  The Endocannabinoid 2-Arachidonoylglycerol Produced by Diacylglycerol Lipase α Mediates Retrograde Suppression of Synaptic Transmission , 2010, Neuron.

[7]  M. Pangalos,et al.  Loss of Retrograde Endocannabinoid Signaling and Reduced Adult Neurogenesis in Diacylglycerol Lipase Knock-out Mice , 2010, The Journal of Neuroscience.

[8]  S. Cuzzocrea,et al.  Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation , 2009, Proceedings of the National Academy of Sciences.

[9]  K. Mackie,et al.  Monoacylglycerol Lipase Limits the Duration of Endocannabinoid-Mediated Depolarization-Induced Suppression of Excitation in Autaptic Hippocampal Neurons , 2009, Molecular Pharmacology.

[10]  J. Long,et al.  Blockade of 2-Arachidonoylglycerol Hydrolysis by Selective Monoacylglycerol Lipase Inhibitor 4-Nitrophenyl 4-(Dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances Retrograde Endocannabinoid Signaling , 2009, Journal of Pharmacology and Experimental Therapeutics.

[11]  M. Poo,et al.  Endocannabinoid-Dependent Homeostatic Regulation of Inhibitory Synapses by Miniature Excitatory Synaptic Activities , 2009, The Journal of Neuroscience.

[12]  K. Mackie,et al.  Cannabinoid signaling in inhibitory autaptic hippocampal neurons , 2009, Neuroscience.

[13]  Ryan A. Kellogg,et al.  Cannabinoid CB1 receptor-dependent long-term depression in autaptic excitatory neurons. , 2009, Journal of neurophysiology.

[14]  P. V. van Rijen,et al.  Hippocampal distribution of vesicular glutamate transporter 1 in patients with temporal lobe epilepsy , 2009, Epilepsia.

[15]  T. Bisogno,et al.  Synthesis and Pharmacological Activity of a Potent Inhibitor of the Biosynthesis of the Endocannabinoid 2‐Arachidonoylglycerol , 2009, ChemMedChem.

[16]  T. Tzounopoulos,et al.  Distinct functional and anatomical architecture of the endocannabinoid system in the auditory brainstem. , 2009, Journal of neurophysiology.

[17]  Masahiko Watanabe,et al.  Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia , 2009, The European journal of neuroscience.

[18]  R. Stevens,et al.  Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain. , 2009, Chemistry & biology.

[19]  Benjamin F. Cravatt,et al.  Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects , 2008, Nature chemical biology.

[20]  Masahiko Watanabe,et al.  Predominant expression of phospholipase Cβ1 in telencephalic principal neurons and cerebellar interneurons, and its close association with related signaling molecules in somatodendritic neuronal elements , 2008, The European journal of neuroscience.

[21]  István Katona,et al.  Endocannabinoid signaling as a synaptic circuit breaker in neurological disease , 2008, Nature Medicine.

[22]  B. Alger,et al.  Metaplastic control of the endocannabinoid system at inhibitory synapses in hippocampus , 2008, Proceedings of the National Academy of Sciences.

[23]  B. Cravatt,et al.  Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. , 2008, Chemical reviews.

[24]  M. Palkovits,et al.  Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain , 2008, Neuroscience.

[25]  Masahiko Watanabe,et al.  Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus , 2008, The Journal of Neuroscience.

[26]  M. Kano,et al.  Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocanabinoid release , 2008, Neuropharmacology.

[27]  Chiayu Q. Chiu,et al.  Input-specific plasticity at excitatory synapses mediated by endocannabinoids in the dentate gyrus , 2008, Neuropharmacology.

[28]  Masahiko Watanabe,et al.  Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area , 2008, Neuropharmacology.

[29]  B. Cravatt,et al.  A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2‐Arachidonoylglycerol , 2007, Chemistry & biology.

[30]  J. Laitinen,et al.  Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors. , 2007, Basic & clinical pharmacology & toxicology.

[31]  Robin M. Murray,et al.  Cannabis, the mind and society: the hash realities , 2007, Nature Reviews Neuroscience.

[32]  Stephen P. H. Alexander,et al.  The complications of promiscuity: endocannabinoid action and metabolism , 2007, British journal of pharmacology.

[33]  K. Mackie,et al.  A Key Role for Diacylglycerol Lipase-α in Metabotropic Glutamate Receptor-Dependent Endocannabinoid Mobilization , 2007, Molecular Pharmacology.

[34]  Pedro Grandes,et al.  Molecular Components and Functions of the Endocannabinoid System in Mouse Prefrontal Cortex , 2007, PloS one.

[35]  Masahiko Watanabe,et al.  Subcellular Arrangement of Molecules for 2-Arachidonoyl-Glycerol-Mediated Retrograde Signaling and Its Physiological Contribution to Synaptic Modulation in the Striatum , 2007, The Journal of Neuroscience.

[36]  M. Kano,et al.  Presynaptic Monoacylglycerol Lipase Activity Determines Basal Endocannabinoid Tone and Terminates Retrograde Endocannabinoid Signaling in the Hippocampus , 2007, The Journal of Neuroscience.

[37]  P. Pacher,et al.  The Endocannabinoid System as an Emerging Target of Pharmacotherapy , 2006, Pharmacological Reviews.

[38]  Beat Lutz,et al.  The Endocannabinoid System Controls Key Epileptogenic Circuits in the Hippocampus , 2006, Neuron.

[39]  Vivien Chevaleyre,et al.  Endocannabinoid-mediated synaptic plasticity in the CNS. , 2006, Annual review of neuroscience.

[40]  T. Freund,et al.  Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses , 2006, The Journal of Neuroscience.

[41]  Masahiko Watanabe,et al.  Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. , 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[42]  Masahiko Watanabe,et al.  The CB1 Cannabinoid Receptor Is the Major Cannabinoid Receptor at Excitatory Presynaptic Sites in the Hippocampus and Cerebellum , 2006, The Journal of Neuroscience.

[43]  David A Lewis,et al.  Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. , 2006, Cerebral cortex.

[44]  Ken Mackie,et al.  Cannabinoid receptors as therapeutic targets. , 2006, Annual review of pharmacology and toxicology.

[45]  K. Mackie,et al.  Depolarization‐induced suppression of excitation in murine autaptic hippocampal neurones , 2005, The Journal of physiology.

[46]  K. Mackie,et al.  Stimulation of Endocannabinoid Formation in Brain Slice Cultures through Activation of Group I Metabotropic Glutamate Receptors , 2005, Molecular Pharmacology.

[47]  Judit K. Makara,et al.  Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus , 2005, Nature Neuroscience.

[48]  Hee-Sup Shin,et al.  Phospholipase Cβ Serves as a Coincidence Detector through Its Ca2+ Dependency for Triggering Retrograde Endocannabinoid Signal , 2005, Neuron.

[49]  T. Freund,et al.  Segregation of two endocannabinoid‐hydrolyzing enzymes into pre‐ and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala , 2004, The European journal of neuroscience.

[50]  Y. Smith,et al.  Distribution of mGluR1α and mGluR5 immunolabeling in primate prefrontal cortex , 2003 .

[51]  Gareth Williams,et al.  Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain , 2003, The Journal of cell biology.

[52]  D. Piomelli.  The molecular logic of endocannabinoid signalling , 2003, Nature Reviews Neuroscience.

[53]  T. Freund,et al.  Role of endogenous cannabinoids in synaptic signaling. , 2003, Physiological reviews.

[54]  P. Castillo,et al.  Heterosynaptic LTD of Hippocampal GABAergic Synapses A Novel Role of Endocannabinoids in Regulating Excitability , 2003, Neuron.

[55]  T. Freund,et al.  Brain monoglyceride lipase participating in endocannabinoid inactivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[56]  F. Fujiyama,et al.  Immunohistochemical localization of candidates for vesicular glutamate transporters in the rat brain , 2002, The Journal of comparative neurology.

[57]  T. Yeo,et al.  Expression of the group I metabotropic glutamate receptor in the hippocampus of patients with mesial temporal lobe epilepsy , 2001, Journal of neurocytology.

[58]  Heping Cheng,et al.  Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses , 2001, Nature.

[59]  M. Kano,et al.  Endogenous Cannabinoids Mediate Retrograde Signals from Depolarized Postsynaptic Neurons to Presynaptic Terminals , 2001, Neuron.

[60]  Anatol C. Kreitzer,et al.  Retrograde Inhibition of Presynaptic Calcium Influx by Endogenous Cannabinoids at Excitatory Synapses onto Purkinje Cells , 2001, Neuron.

[61]  T. Freund,et al.  GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus , 2000, Neuroscience.

[62]  Ayae Kinoshita,et al.  Differential Presynaptic Localization of Metabotropic Glutamate Receptor Subtypes in the Rat Hippocampus , 1997, The Journal of Neuroscience.

[63]  D. Piomelli,et al.  A second endogenous cannabinoid that modulates long-term potentiation , 1997, Nature.

[64]  R. Faull,et al.  Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain , 1997, Neuroscience.

[65]  I. Blümcke,et al.  Immunohistochemical distribution of metabotropic glutamate receptor subtypes mGluR1b, mGluR2/3, mGluR4a and mGluR5 in human hippocampus , 1996, Brain Research.

[66]  R Lujan,et al.  Perisynaptic Location of Metabotropic Glutamate Receptors mGluR1 and mGluR5 on Dendrites and Dendritic Spines in the Rat Hippocampus , 1996, The European journal of neuroscience.

[67]  Z. Vogel,et al.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. , 1995, Biochemical pharmacology.

[68]  M. Herkenham,et al.  Cannabinoid receptor binding and messenger RNA expression in human brain: An in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains , 1994, Neuroscience.

[69]  S. Munro,et al.  Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.

[70]  D. Gibson,et al.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.

[71]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[72]  M. Herkenham,et al.  Cannabinoid receptor localization in brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[73]  A. Howlett,et al.  Determination and characterization of a cannabinoid receptor in rat brain. , 1988, Molecular pharmacology.

[74]  T. Freund,et al.  Dynamic changes of CB 1 receptor expression in hippocampi of epileptic mice and humans , 2011 .

[75]  Masahiko Watanabe,et al.  Endocannabinoid-mediated control of synaptic transmission. , 2009, Physiological reviews.

[76]  B. Alger,et al.  Multiple mechanisms of endocannabinoid response initiation in hippocampus. , 2006, Journal of neurophysiology.

[77]  Y. Smith,et al.  Distribution of mGluR1alpha and mGluR5 immunolabeling in primate prefrontal cortex. , 2003, The Journal of comparative neurology.

[78]  T. Sugiura,et al.  2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. , 1995, Biochemical and biophysical research communications.